PATENT CLAIM ANALYSIS

Application Number: 16008219
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Disclosed are the uses of compositions containing not less than 10% w/w of Oroxylin A, not less than 10% w/w of Baicalein and not less than 2% w/w of Chrysin in inhibiting the activity and expression of β secretase. The invention also discloses the reduction of amyloid content in PS-70 cells using the abovementioned composition. Further, the invention mentions the use of the composition for the therapeutic management of β secretase mediated disorders.

Claim (Index 9):
The method as in  claim 7 , wherein the \u03b2 secretase mediated disorders are selected from the group consisting of Alzheimer's disease, Parkinson's disease, Prion related diseases, cognitive decline, mild cognitive impairment, vascular dementia, Down's syndrome, Hereditary cerebral hemorrhage with amyloidosis dutch type (HCHWA-D), and glaucoma.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.7234
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15805320', '13377508', '14855065', '11523507', '10480954']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7876679008543845
- 35 USC 102 Novelty (BERT): 0.505607613171155
- Combined Prediction Score: 0.7594618720860616
- Mean Citation Score: 201.282908
- Max Citation Score: 248.95978
- Similarity Product: 164.42931064549688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test